Burgeoning Molecular Diagnostics Market Propels the Global DNA Probes-Based Diagnostics Market, According to New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive global report on DNA Probe-Based Diagnostics markets. The global market for DNA Probe-Based Diagnostics is forecast to reach US$30 billion by the year 2017, driven by the rapidly expanding molecular diagnostics market. Growth in the marketplace is also expected to stem from affluent population and widening health insurance as well as medical reimbursements, which are making expensive cutting edge diagnostic tools such as DNA-based diagnostics increasingly affordable.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
DNA Probes-Based Diagnostics: A Global Strategic Business Report

San Jose, California (PRWEB) May 03, 2012

Follow us on LinkedIn – In the medical diagnostics laboratories of the 21st century, the ability to detect nucleic acids and proteins reign supreme. And given the need to rapidly and inexpensively determine the relevant DNA sequence information in a given organism, the potential of DNA probes-based diagnostics is huge. DNA probes also render themselves as a powerful tool for chromosomal mapping of single and multiple copy genes in the haploid genome. This invariably spells out an expansion in its applications in delineation and classification of many genetic diseases. The future envisages a DNA probe, which offers the ability to detect complex interrelationships between multiple gene expression and environmental factors, at the molecular level. This will help in detecting diseases, which are not the result of single-gene, or monogenetic disorders.

In the upcoming years, DNA diagnostic technologies are set to achieve superior efficiencies and improved activity in numerous application areas, including healthcare, biomedical research, toxicology, bioremediation, forensics and personnel identification, environmental monitoring, biomass operations, industrial processing, monitoring of infectious agents, and quality control in the food industry, animal husbandry, and agriculture. Also, the boom in the molecular diagnostics market is beginning to echo downstream into the DNA-probe based diagnostics segment. Further, affluent population and widening health insurance and medical reimbursements are additionally making expensive cutting edge diagnostic tools, such as DNA-based diagnostics, increasingly affordable.

The US represents the largest regional market for DNA Probe-Based Diagnostics market worldwide, as stated by the new market research report on DNA Probes-Based Diagnostics. In the US, the rapid growth of DNA-based diagnostics is leading to the development of new tests for the treatment of non-contagious diseases, such as diseases related to aging or chronic diseases. DNA-based diagnostic testing is rapidly entering the cancer setting as well. Europe trails behind the US, while the Asia-Pacific market is projected to register the fastest compounded annual growth rate of 21% during the analysis period. Infectious Diseases represents the key end-use market for DNA probes-based diagnostics worldwide. However, fastest growth is expected to emerge from Genetic Predisposition.

Despite the positive outlook, the marketplace continues to be plagued by challenges such as miniaturization, parallelization, and automation. In addition to these key challenges, improvements, and procedural refinement needs to be implemented in the areas of sample preparation, assay technology, detection systems, integration, data management and analysis. The culminated effect of all of these variables will help in determining the efficacy of the technology’s application in clinical diagnostics, in the years to come.

Major players profiled in the report include Abbott Molecular, Affymetrix, Inc., Becton, Dickinson & Company, Beckman Coulter Inc., bioMérieux, Celera Group, Gen-Probe Inc., Genzyme Corp., Luminex Molecular Diagnostics, QIAGEN, Roche Diagnostics, Siemens Healthcare Diagnostics, among others.

The research report titled “DNA Probes-Based Diagnostics: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the DNA probe-based diagnostics markets, current market trends, key growth drivers, recent product introductions, recent industry activity, and profiles of major/niche global as well as regional market participants. The report provides annual sales estimates and projections for DNA Probe-Based Diagnostics market for the years 2009 through 2017 for the following geographic markets - US, Canada, Japan, Europe, Asia-Pacific and Latin America. Key application areas analyzed include Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others. Also, a six-year (2003-2008) historic analysis is provided for an additional perspective.

For more details about this comprehensive market research report, please visit –
http://www.strategyr.com/DNA_Probes_based_Diagnostics_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/
###


Contact

Attachments